Takeda and Zydus Cadila partner to address the global threat of Chikungunya

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcontinent. In recent decades mosquito vectors of chikungunya have spread to Europe and the Americas.ⁱ According to the Centers for Disease Control and Prevention (CDC) in the USA, there is currently no vaccine to prevent or medicine to treat chikungunya virus infectionⁱⁱ. ...

Source : http://me-newswire.net//news/18688/en...